Holzkirchen, Germany

Dagmar Zeh-Herwerth

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Hexal Ag. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dagmar Zeh-Herwerth. Retrieved from https://idiyas.com/inventor/dagmar-zeh-herwerth

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dagmar Zeh-Herwerth: Innovator in Transdermal Drug Delivery

Introduction

Dagmar Zeh-Herwerth is a notable inventor based in Holzkirchen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of transdermal drug delivery systems. His innovative approach has led to the creation of a unique patch designed for the transdermal application of pergolid.

Latest Patents

Dagmar holds 1 patent for his invention titled "Patch for transdermal application for pergolid." This invention relates to a patch that facilitates the transdermal delivery of pergolid and its pharmaceutically acceptable salts, providing a new method for administering this medication.

Career Highlights

Throughout his career, Dagmar has worked with prominent companies in the pharmaceutical industry, including Hexal AG and Wilfried Fischer. His experience in these organizations has allowed him to refine his skills and contribute to advancements in drug delivery technologies.

Collaborations

Dagmar has collaborated with several professionals in his field, including Wilfried Fischer and Anna Sendl-Lang. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Dagmar Zeh-Herwerth's work in transdermal drug delivery exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions continue to influence the way medications are administered, enhancing patient care and treatment outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…